Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.46 CHF | -1.35% |
|
+3.98% | +2.63% |
11/07 | FTSE 100 retreats from peak as growth concerns weigh | RE |
11/07 | FTSE 100 eases from record levels amid soft GDP | AN |
Summary: UBS Group AG
- According to MSCI, the company's ESG score for its industry is good.
Highlights: UBS Group AG
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The group's high margin levels account for strong profits.
Weaknesses: UBS Group AG
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings Chart: UBS Group AG
Source: Surperformance
ESG chart: UBS Group AG
Source: MSCI
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
- | - | 11TCr | |||
17TCr | |||||
9.05TCr | |||||
5.45TCr | |||||
5.11TCr | |||||
2.24TCr | |||||
Average | 8.31TCr | ||||
Weighted average by Cap. |
Investor (Composite)
-
Trader (Composite)
ESG MSCI
AA
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
-
Valuation
P/E
EV/Revenue
-
EV/EBITDA
-
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- UBSG Stock
- Ratings UBS Group AG
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition